| | | | | |
REPL Replimune Group, Inc. | $11,6200 | -0,09% | $960,31M | $7,37M | |
| $57,6000 | +1,05% | $957,77M | $160,72K | |
AIO Virtus Artificial Intelligence & Technology Opportunities Fund | $27,7900 | +0,00% | $957,06M | $115,05K | |
AVTX Avalo Therapeutics, Inc. Common Stock | $18,0800 | -0,66% | $956,69M | $1,78M | |
| $54,4400 | -0,40% | $955,17M | $99,00K | |
SANA Sana Biotechnology, Inc. Common Stock | $3,4100 | -0,29% | $951,75M | $3,07M | |
ABX Abacus Global Management, Inc. | $9,9900 | +0,81% | $950,59M | $454,81K | |
ANRO Alto Neuroscience Inc. | $27,0400 | +0,00% | $948,94M | $493,61K | |
GDRX GoodRx Holdings, Inc. Class A Common Stock | $2,8100 | +0,36% | $948,29M | $986,71K | |
RHLD Resolute Holdings Management, Inc. | $133,96 | +0,00% | $948,28M | $132,75K | |
BTZ BlackRock Credit Allocation Income Trust | $10,1600 | +0,00% | $948,17M | $172,92K | |
DBVT DBV Technologies S.A. | $16,0600 | +0,31% | $947,57M | $194,55K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | $13,3900 | +0,38% | $947,08M | $3,41K | |
HEPS D-Market Electronic Services & Trading American Depositary Shares | $2,9000 | +0,00% | $946,64M | $231,84K | |
BMEZ BlackRock Health Sciences Term Trust | $15,1300 | +0,00% | $945,64M | $143,32K | |
